BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REGN20934 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of REGN20934\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07594093-11305@assetmemo.bio
DTSTAMP:20261121T005403Z
DTSTART;VALUE=DATE:20270222
DTEND;VALUE=DATE:20270223
SUMMARY:REGN20934: Phase 1 readout est. (NCT07594093)
DESCRIPTION:REGN20934\, phase 1\, Obesity.\nStudy: Safety and Drug Concentr
 ations of REGN20934 in Adults With Overweight or Obesity\nEstimated primar
 y completion: 22 February 2027. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/regn20934#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT07594093
URL:https://assetmemo.bio/drug/regn20934#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
